Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1077768
Abstract: Introduction Multiple myeloma (MM) is still an incurable plasma cell malignancy. The efficacy of immunotherapy on MM remains unsatisfactory, and the underlying molecular mechanisms still are not fully understood. Methods In this study, we delineated… read more here.
Keywords: metabolic processes; multiple myeloma; immunosuppressive microenvironment; aberrant metabolic ... See more keywords